Vitaly Pirotsky, MS, MBA joined atai Life Sciences in 2021.
Previously, Vitaly was a Program Lead at the Gates Medical Research Institute where he was responsible for the product strategy & development, supporting clinical trials, regulatory submissions, due diligence efforts, and partnerships management.
Prior to that, he spent 18 years in the Biotech/Pharma industry at a number of companies (Boehringer Ingelheim, Pfizer BioPharma, Alnylam, KaryoPharm, Epizyme) as well as venture-backed biotech startups where he was responsible for the program leadership, portfolio management, strategy development, and execution. Additionally, Vitaly is a part of the biotech angel group focused on assessing and investing in breakthrough technologies.
Vitaly holds Master’s degree in Analytical Chemistry, MBA as well as completed executive leadership courses at Harvard Kennedy School of Government.